The Human Monoacylglycerol Acyltransferase 2 Inhibitor VB‐85387 Is Associated With Weight Loss in Mice With Obesity

ABSTRACT Background GLP‐1 therapies for obesity are limited by side effects and weight regain is common after treatment ends. Therefore, alternative treatments with new mechanisms are needed for sustained weight loss. Human MOGAT2 regulates triglyceride metabolism and its inhibition reduces weight i...

Celý popis

Podrobná bibliografie

Hlavní autoři:	J. Jose Corbalan, Pranavi Jagadeesan, Chia‐Yu Huang, James R. Beasley, Joseph T. Nickels Jr.
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2026-04-01
Edice:	Obesity Science & Practice
Témata:	lipids monoacylglycerol acyltransferase nutrition obesity weight loss
On-line přístup:	https://doi.org/10.1002/osp4.70131
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!